Allen Holding Inc.
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 7, 2024), Allen Holding Inc. reported 14 stock positions worth $927.1 million. Its top holding was Coca-Cola (KO) at 46.5% of the portfolio, followed by Berkshire Hathaway Class A (BRK.A, 27.8%) and Palantir Technologies Class A (PLTR, 11.0%). Compared with Q2 2024, it added to 3 and reduced 2. The biggest buy was Pfizer (PFE, shares +100%) and the biggest sale Argan (AGX, shares −24%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0000919489
- Portfolio Value
- $927.1M (Q3 2024)
- SEC Filing
- 0001214659-24-018527 ↗ filed Nov 7, 2024
Holdings Value
Holdings 14 stocks · $927.1M
| KO The Coca-Cola Co. | 46.50% | 6,000,000 | $431.2M | No change |
| BRK.A Berkshire Hathaway Inc. Class A | 27.81% | 373 | $257.8M | No change |
| PLTR Palantir Technologies Inc. Class A | 11.03% | 2,750,000 | $102.3M | Reduce -8.3% |
| BAC Bank of America Corp. filed as BANK AMERICA CORP | 4.49% | 1,050,000 | $41.7M | No change |
| PPLI People Inc. filed as IAC INC | 3.49% | 601,100 | $32.4M | Add +4.0% |
| PFE Pfizer Inc. | 3.12% | 1,000,000 | $28.9M | Add +100.0% |
| AFRM Affirm Holdings Inc. | 1.12% | 255,262 | $10.4M | Add +743.5% |
| JPM JPMorgan Chase & Co. | 0.68% | 30,000 | $6.3M | No change |
| ANGI Angi Inc. | 0.47% | 1,700,000 | $4.4M | No change |
| TRIP Tripadvisor Inc. | 0.28% | 181,826 | $2.6M | No change |
| IBRX Immunitybio Inc. | 0.28% | 687,571 | $2.6M | No change |
| VMEO Vimeo Inc. | 0.27% | 487,049 | $2.5M | No change |
| AGX Argan Inc. | 0.26% | 24,000 | $2.4M | Reduce -24.3% |
| MTCH Match Group Inc. | 0.18% | 45,000 | $1.7M | No change |
Portfolio Sells Q2 2024 → Q3 2024
Portfolio Buys Q2 2024 → Q3 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 10 | $1.0B | KO, BRK.A, PLTR, PFE, PPLI |
| Q1 2026 | 9 | $1.0B | KO, PLTR, BRK.A, PFE, PPLI |
| Q4 2025 | 9 | $1.0B | KO, PLTR, BRK.A, PFE, PPLI |
| Q3 2025 | 9 | $1.1B | KO, PLTR, BRK.A, PFE, PPLI |
| Q2 2025 | 10 | $1.0B | KO, PLTR, BRK.A, PFE, PPLI |
| Q1 2025 | 14 | $961.1M | KO, BRK.A, PLTR, PPLI, PFE |
| Q4 2024 | 14 | $911.8M | KO, BRK.A, PLTR, PFE, PPLI |
| Q3 2024 | 14 | $927.1M | KO, BRK.A, PLTR, BAC, PPLI |
| Q2 2024 | 14 | $800.3M | KO, BRK.A, PLTR, BAC, PPLI |
| Q1 2024 | 14 | $794.6M | KO, BRK.A, PLTR, PPLI, BAC |